Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling

International Journal of Drug Policy

Volumn 20, Issue 1, 2009, Pages 14-27

  Semaan, Salaam ^a   Santibanez, Scott ^a   Garfein, Richard S ^b   Heckathorn, Douglas D ^c   Des Jarlais, Don C ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Ethics; Hidden populations; HIV disclosure; Incentives; Injection drug user; Men who have sex with men; Respondent driven sampling; Sexual risk

Indexed keywords

DRUG USE; HIGH RISK BEHAVIOR; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; INTERPERSONAL COMMUNICATION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RESEARCH ETHICS; RESEARCH SUBJECT; RISK REDUCTION; SAMPLING; SEXUALITY; SHORT SURVEY;

CONFIDENTIALITY; DATA COLLECTION; DRUG USERS; DUTY TO WARN; ETHICS COMMITTEES, RESEARCH; GOVERNMENT REGULATION; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; INFORMED CONSENT; MOTIVATION; PATIENT SELECTION; PROFESSIONAL ROLE; REWARD; RISK REDUCTION BEHAVIOR; SAMPLING STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 57549108547     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.12.006     Document Type: Short Survey

References (109)

1. Abdul-Quader A.S., Heckathorn D.D., McKnight C., Bramson H., Nemeth C., Sabin K., et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: Findings from a pilot study. Journal of Urban Health 83 (2006) 459-476
2. Abdul-Quader A.S., Heckathorn D.D., Sabin K., and Saidel T. Implementation and analysis of respondent driven sampling: Lessons learned from the field. Journal of Urban Health 83 (2006) 1-5
3. Akabayashi A., and Slingsby B.T. Informed consent revisited: Japan and the U.S. The American Journal of Bioethics 6 (2006) 9-14
4. Boter H., van Delden J.J.M., de Hann R.J., Rinkel G.J.E., and for the home evaluation of stroke induced aid study group. Modified informed consent procedure: Consent to postponed information. British Medical Journal 327 (2003) 284-286
5. Broadhead R.S., Heckathorn D.D., Grund J.P., Stern L.S., and Anthony D.L. Drug users versus outreach workers in combating AIDS: Preliminary results of a peer-driven intervention. Journal of Drug Issues 25 (1995) 531-564
6. Broadhead R.S., Heckathorn D.D., Weakliem D.L., Anthony D.L., Madray H., Mills R.J., et al. Harnessing peer networks as an instrument for AIDS prevention: Results from a peer-driven intervention. Public Health Reports 113 (1998) 42-57
7. Catania J.A., Gibson D., Chitwood D., and Coates T. Methodological problems in AIDS behavioral research: Influences of measurement error and participation studies in studies of sexual behavior. Psychology Bulletin 108 (1990) 339-362
8. Centers for Disease Control and Prevention. Guidelines for defining public health research and public health non-research. (1999), Centers for Disease Control and Prevention, Atlanta, GA
9. Centers for Disease Control and Prevention. Advancing HIV prevention: New strategies for a changing epidemic-United States 2003. Morbidity and Mortality Weekly Report 52 (2003) 329-332
10. Clements-Nolle K., Marx R., Guzman R., and Katz M. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: Implications for public health intervention. American Journal of Public Health 91 (2001) 915-921
11. Cooper H., and Hedges L.V. The handbook of research synthesis (1994), Russell Sage Foundation, New York
12. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects (2003), World Health Organization, Geneva. http:www.cioms.ch/frame_guidelines.htm
13. Crepaz N., and Marks G. Serostatus disclosure, sexual communication and safer sex in HIV-positive men. AIDS Care 15 (2003) 379-387
14. Deci E.L., and Ryan R.M. Intrinsic motivation and self-determination in human behaviour (1985), Plenum, New York
15. Deren S., Stephens R.C., Rees Davis W., Feucht T.E., and Tortu S. The impact of providing incentives for attendance at AIDS prevention services. Public Health Reports 109 (1994) 548-554
16. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Abdul-Qauder A., Heckathorn D.D., et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 21 (2007) 231-235
17. Des Jarlais D.C., Perlis T., Arasteh K., Hagan H., Milliken J., Braine N., et al. "Informed altruism" and "partner selection" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. Journal of Acquired Immune Deficiency Syndrome 35 (2004) 158-166
18. Des Jarlais D.C., and Semaan S. Interventions to reduce the sexual risk behavior of injecting drug users. International Journal of Drug Policy 16S (2005) S58-S66
19. Eisenberger R., and Cameron J. Detrimental effects of reward: Reality or myth?. American Psychologist 51 (1996) 1153-1166
20. Emanuel E.J. Ending concerns about undue inducement. Journal of Law and Medical Ethics 32 (2004) 100-105
21. Emanuel E.J., Wendler D., Killen J., and Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. Journal of Infectious Diseases 189 (2004) 130-137
22. Fairchild A.L., and Bayer R. Ethics and the conduct of public health surveillance. Science 303 (2004) 631-632
23. Fairchild A.L. Dealing with humpty dumpty: Research, practice, and the ethics of public health surveillance. Journal of Law, Medicine, and Ethics 31 (2005) 615-623
24. Fernandez C.V., Kodish E., and Weijer C. Informing study participants of research results: An ethical perspective. IRB: Ethics & Human Research 25 (2003) 12-19
25. Festinger D.S., Marlowe D.B., Croft J.R., Dugosh K.L., Mastro N.K., Lee P.A., et al. Do research payments precipitate drug use or coerce participation?. Drug and Alcohol Dependence 78 (2005) 275-281
26. Fisher C.B. Ethics in drug abuse and related HIV risk research. Applied Developmental Sciences 8 (2004) 91-103
27. Fitzgerald D.W., Wasunna A., and Pape J.W. Ten questions institutional review boards should ask when reviewing international clinical research protocols. IRB: Ethics & Human Research 25 2 (2003) 14-18
28. Foddy B., and Savulescu J. Addiction and autonomy: Can addicted people consent to the prescription of their drug of addiction. Bioethics 20 (2006) 1-15
29. Frost S.D.W., Brouwer K.C., Firestone-Cruz M.A., Ramos R., Ramos M.E., Lozada R.M., et al. Respondent driven sampling of injection-drug users in two U.S.-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health 83 (2006) 83-97
30. Fry C., and Dwyer R. For love or money? An exploratory study of why injecting drug users participate in research. Addiction 96 (2001) 1319-1325
31. Fry C.L., Hall W., Ritter A., and Jenkinson R. The ethics of paying drug users who participate in research: A review and practical recommendations. Journal of Empirical Research on Human Research Ethics 1 (2006) 21-36
32. Gagnon J.H., Lindenbaum S., Martin J.L., May R.M., Menken J., Turner C.F., et al. Sexual behavior and AIDS. In: Turner C.F., Miller H., and Moses L. (Eds). Sexual behavior and intravenous drug use (1989), National Academy Press, Washington, DC 73-185
33. Gallagher K.M., Denning P.D., Allen D.R., Nakashima A.K., and Sullivan P.S. Use of rapid behavioral assessments to determine the prevalence of HIV risk behaviors in high-risk populations. Public Health Reports 122 Suppl. 1 (2007) 56-62
34. Galton F. English men of science: Their nature and nurture (1874), Macmillan, London
35. Gardner W., Hoge S.K., Bennet N., Roth L.H., Lidz C.W., Monahan J., et al. Two scales for measuring patients' perception of coercion during mental hospital admission. Behavioral Sciences & the Law 11 (1993) 307-321
36. Golden M.R., Hogben M., Handsfiled H., St. Lawrence J.S., Potterat J.J., and Holmes K. Partner notification for HIV and STD in the United States: Low coverage for gonorrhea, chlamydial infection, and HIV. Sexually Transmitted Diseases 30 (2003) 490-496
37. Golub A., and Johnson B.D. How much do Manhattan-arrestees spend on drugs?. Drug and Alcohol Dependence 76 (2004) 235-246
38. Gordon B.G., Brown J., Kratochvil C., and Prentice E.D. Paying research subjects. In: Amdur R.J., and Bankert E.A. (Eds). Institutional review board: Management and function. 1st ed. (2002), Jones and Bartlett Publishers, Sudbury, MA 185-190
39. Grady C. Money for research participation: Does it jeopardize informed consent?. American Journal of Bioethics 1 (2001) 41-44
40. Grady C., Dickert N., Jawtez T., Gensler G., and Emanuel E. An analysis of U.S. practices of paying research participants. Contemporary Clinical Trials 26 (2005) 365-375
41. Halpern S.D. Towards evidence based bioethics. British Medical Journal 331 (2005) 901-903
42. Hawkins J.S., and Emanuel E.J. Clarifying confusions about coercion. Hastings Center Report 35 (2005) 16-19
43. Hearnshaw H. Comparison of requirements of research ethics committees in 11 European countries for a non-invasive international study. British Medical Journal 328 (2004) 140-141
44. Heckathorn D. Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems 44 (1997) 174-199
45. Heckathorn D. Respondent-driven sampling: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems 49 (2002) 11-34
46. Heckathorn, D. D. (2007). Extensions of respondent-driven sampling: Analyzing continuous variables and controlling for differential recruitment. Sociological Methodology, 27.
47. Heckathorn D.D., and Broadhead R.S. Rational choice, public policy, and AIDS. Rationality and Society 8 (1996) 235-260
48. Heckathorn D.D., Abdul-Quader A.S., Sabin K., Mello M., Diaz J., Chinaglia M., et al. Respondent-driven sampling: Quantifying HIV prevalence, HIV risk behaviour, and the network embeddedness of risk behaviour in developing countries. Paper presented at the conference on Infectious Diseases in Poor Countries and the Social Sciences. Cornell University, Ithaca, NY, September 7, 2007 (2007)
49. Heckathorn D.D., Semaan S., Broadhead R.S., and Hughes J.J. Extensions of respondent-driven sampling: A new approach to the study of injection-drug users aged 18-25. AIDS and Behavior 6 (2002) 55-67
50. Holtgrave D.R. Estimation of annual HIV transmission rates in the United States, 1978-2000. Journal of Acquired Immune Deficiency Syndrome 35 (2004) 89-92
51. Holtgrave D.R., and Anderson T. Utilizing HIV transmission rates to assist in prioritizing HIV prevention services. International Journal of STD & AIDS 15 (2004) 789-792
52. Holtgrave D.R., and Pinkerton S.D. Can increasing awareness of HIV seropositivity reduce infections by 50% in the United States?. Journal of Acquired Immune Deficiency Syndrome 44 (2007) 360-363
53. Hughes J.H. Paying injection-drug users to educate and recruit their peers: Why participant-driven interventions are an ethical public health model?. Quality Management in Health Care 7 (1999) 4-12
54. Johnson W.D., Semaan S., Hedges L.V., Ramirez G., Mullen P.D., and Soglow E. A protocol for the analytical aspects of a systematic review of HIV prevention research. Journal of Acquired Immune Deficiency Syndromes 30 (2002) S62-S72
55. Joint United Nations Program on AIDS. Opening up the HIV/AIDS epidemic: Guidance on encouraging beneficial disclosure, ethical partner counseling and appropriate use of HIV case reporting (2000), UN AIDS, Geneva
56. Kalton G. Sampling considerations in research on HIV risk and illness. In: Ostrow D.G., and Kessler R.C. (Eds). Methodological issues in AIDS behavioral research (1993), Plenum Press, New York 53-74
57. Katz D., Caplan A.L., and Merz J.F. All gifts large and small: Toward an understanding of the ethics of pharmaceutical industry gift-giving. The American Journal of Bioethics 3 (2003) 39-46
58. Kish L. Taxonomy of elusive populations. Journal of Official Statistics 7 (1991) 340-347
59. Klein S.J. Screening for risk of domestic violence within HIV partner notification: Evolving practice and emerging issues. Journal of Public Health Management Practice 7 (2001) 46-49
60. Kleinig J. Ethical issues in substance use intervention. Substance Use & Misuse 39 (2004) 369-398
61. Klovdahl A.S. Social network research and human subjects protection: Towards more effective infectious disease control. Social Networks 27 (2005) 119-137
62. Knoppers B.M., Joly Y., Simard J., and Durocher F. The emergence of an ethical duty to disclose genetic research results: International perspectives. European Journal of Human Genetics 14 (2006) 1170-1178
63. Lansky A., Abdul-Quader A.S., Cribbin M., Hall T., Finlayson T.J., Garfein R.S., et al. Developing an HIV behavioral surveillance system for injecting drug users: The national HIV behavioral surveillance system. Public Health Reports 122 (2007) S48-S55
64. Latkin C.A., Knowlton A.R., Forman V.L., Hoover D.R., Schroeder J.R., Hachey M., et al. Injection-drug users' disclosure of HIV seropositive status to network members. AIDS and Behavior 5 (2001) 297-305
65. Latterman J., and Merz J.F. How much are subjects paid to participate in research?. American Journal of Bioethics 1 (2001) 45-46
66. Laumann E.O., Michael R., Gagnon J., and Michaels S. The social organization of sexuality: Sexual practices in the United States (1994), University of Chicago Press, Chicago, IL
67. Lemmens T., and Miller P. The human subjects trade: Ethical and legal issues surrounding recruitment incentives. Journal of Law Medicine & Ethics 31 (2003) 398-418
68. Magnani R., Sabin K., Saidel T., and Heckathorn D.D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS (2005) S67-S72
69. Margolis L.H. Taking names: The ethics of indirect recruitment in research on sexual networks. Journal of Law, Medicine, and Ethics 28 (2000) 159-164
70. McKnight C., Des Jarlais D., Bramson H., Tower L., Abdul-Qader A.S., Nemeth C., et al. Respondent-driven sampling in a study of drug users in New York City: Notes from the field. Journal of Urban Health 83 (2006) 54-59
71. Miller F., and Rosenstein D.L. Reporting of ethical issues in publications of medical research. Lancet 360 (2002) 1326-1328
72. National Bioethics Advisory Commission. Ethical and policy issues in international research: clinical trials in developing countries vol. 1 (2003), Department of Commerce, Technology Administration, National Technical Information Service, Bethesda, US
73. Nuffield Council on Bioethics. The ethics of health care related research in developing countries: A follow-up discussion paper (2005), Nuffield Council on Bioethics, London, UK
74. Office of Protection from Research Risk (1991). Protection of human subjects (45 CFR 46). http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm.
75. Parsons J.T., Van Ora J., Missildine W., Purcell D.W., and Gomez C.A. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Education and Prevention 16 (2004) 459-475
76. Passin W.F., Kim A.S., Hutchinson A.B., Crepaz N., Herbst J.H., Lyles C.M., et al. A systematic review of HIV partner counseling and referral services: Client and provider attitudes, preferences, practices, and experiences. Sexually Transmitted Diseases 33 (2006) 320-328
77. Paxton S. The paradox of public HIV disclosure. AIDS Care 14 (2002) 559-567
78. Platt L., Wall M., Rhodes T., Judd A., Hickman M., Johnston L., et al. Methods to recruit hard-to-reach groups: Comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. Journal of Urban Health 83 (2006) 39-53
79. Ramirez-Valles J., Heckathorn D.D., Vazquez R., Diaz R.M., and Campbell R.T. From networks to populations: The development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS and Behavior 19 (2005) 1-16
80. Rhodes T., Singer M., Bourgois P., Friedman S.R., and Strathdee S.A. The social structural production of HIV risk among injection drug users. Social Science and Medicine 61 (2005) 1026-1044
81. Rivera R., Borasky D., Rice R., Carayon F., and Wong E. Informed consent: An international researchers' perspective. American Journal of Public Health 97 (2007) 25-30
82. Robinson W., Risser J., McGoy S., Becker A., Rehman H., Jefferson M., et al. Recruiting injection drug users: A three-site comparison of results and experiences with respondent-driven and targeted sampling procedures. Journal of Urban Health 83 (2006) 29-38
83. Rose J.W. To tell or not to tell: Legislative imposition of partner notification duties for HIV patients. The Journal of Legal Medicine 22 (2001) 107-123
84. Roy D.J. Injection drug use and HIV/AIDS: An ethics commentary on priority issues (2000), Health Canada
85. Salganik M.J. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. Journal of Urban Health 83 (2006) 98-112
86. Semaan S., Des Jarlais D.C., and Malow R.M. Sexually transmitted diseases among illicit drug users in the United States: The need for interventions. In: Aral S.O., and Douglas J. (Eds). Behavioral interventions for prevention and control of sexually transmitted diseases (2007), Springer, New York, NY 397-430
87. Semaan S., Klovdahl A., and Aral S.O. Protecting the privacy, confidentiality, relationships, and medical safety of sex partners in partner notification and management studies. The Journal of Research Administration 35 (2004) 39-53
88. Semaan S., Lauby J., and Liebman J. Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Review 4 (2002) 213-223
89. Semaan S., and Leinhos M. The ethics of public health practice for the prevention and control of STDs. In: Aral S.O., and Douglas J. (Eds). Behavioral interventions for prevention and control of sexually transmitted diseases (2007), Springer, New York, NY 517-548
90. Sharp H.M. When "minimal risk" research yields clinically significant data, maybe the risks aren't so minimal. American Journal of Bioethics 4 (2004) W32-W36
91. Simic M., Johnston L., Plat L., Baros S., Andjelkovic V., Novotny T., et al. Exploring barriers to respondent driven sampling in sex worker and drug-injecting sex worker populations in Eastern Europe. Journal of Urban Health 83 (2006) 6-15
92. Simmerling, M., Schwegler, B., Sieber, J., & Lindgren, J. (2007). Introducing a new paradigm for ethical research in the social, behavioral, and biomedical sciences: Part I. http://ssrn.com/abstract=897322.
93. Snider D.E., and Stroup D.F. Defining research when it comes to public health. Public Health Reports 112 (1997) 29-112
94. Stormer A., Tun W., Guli L., Harxhi A., Bodanovskaia Z., Yakovleva A., et al. An analysis of respondent driven sampling with injection drug users (IDU) in Albania and the Russian Federation. Journal of Urban Health 83 (2006) 73-82
95. Sudman S., Sirken M., and Cowan C. Sampling rare and elusive populations. Science 240 (1988) 991-996
96. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1978). The Belmont report: Ethical principles and guidelines for the protection of human subjects of research (Rep. no. DHEW Publication no. (OS 78-0012)). Washington, DC: U.S. Government Printing Office.
97. Tiffany J.S. Respondent-driven sampling in participatory research contexts: Participant-driven recruitment. Journal of Urban Health 83 (2006) i113-i124
98. Tishler C., and Bartholomae S. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. Journal of Pharmacology 42 (2002) 363-373
99. Tobin K.E., Muessig K.E., and Latkin C.A. HIV seropositive drug users' attitudes towards partner notification (PCRS): Results from the SHIELD study in Baltimore, Maryland. Patient Education and Counseling 67 (2007) 137-142
100. Wang J., Carlson R.G., Falck R.S., Siegal H.A., Rahman A., and Li L. Respondent-driven sampling to recruit MDMA users: A methodological assessment. Drug and Alcohol Dependence 78 (2005) 147-157
101. Warszawski J., and Meyer L. Sex difference in partner notification: Results from three population based surveys in France. Sexually transmitted Infections 78 (2002) 45-49
102. Weijer C., and Anderson J.A. The ethics wars: Dispute over international research. Hastings Center Report 31 (2001) 18-20
103. Wiener L., and El Lyon M. HIV disclosure: Who knows? Who needs to know? Clinical and ethical considerations. In: Lyon M., and D'Angelo L. (Eds). Teenagers, HIV and AIDS: Insights from youths living with the virus (2007), Praeger, Westport, CT 105-126
104. Wilkinson M., and Moore A. Inducement in research. Bioethics 11 (1997) 373-389
105. World Bank Group. Public health surveillance toolkit (2002), World Bank Group
106. World Medical Association. (2000). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Geneva: World Medical Association. http://www.wma.net/e/policy/17-c_e.html.
107. World Health Organization. Research Ethics Review Committee. The role of ethics review committees in public health surveillance (2004), World Health Organization, Geneva
108. Yeka W., Maibani-Michie G., Prybylski D., and Colby D. Application of respondent driven sampling to collect baseline data on FSW and MSM for HIV risk reduction interventions in two urban centers in Papua New Guinea. Journal of Urban Health 83 (2006) 60-72
109. Zion D. Does autonomy require freedom? The importance of options in international HIV/AIDS research. Health Care Analysis 13 (2005) 189-202